References
Acar, Ahmet, Daniel Nichol, Javier Fernandez-Mateos, George D.
Cresswell, Iros Barozzi, Sung Pil Hong, Nicholas Trahearn, et al. 2020.
“Exploiting Evolutionary Steering to Induce Collateral Drug
Sensitivity in Cancer.” Nature Communications 11 (1):
1923. https://doi.org/10.1038/s41467-020-15596-z.
Al-Hajj, Muhammad, Max S. Wicha, Adalberto Benito-Hernandez, Sean J.
Morrison, and Michael F. Clarke. 2003. “Prospective Identification
of Tumorigenic Breast Cancer Cells.” Proceedings of the
National Academy of Sciences 100 (7): 3983–88. https://doi.org/10.1073/pnas.0530291100.
Bachman, Jeff W. N., and Thomas Hillen. 2013. “Mathematical
Optimization of the Combination of Radiation and Differentiation
Therapies for Cancer.” Frontiers in Oncology 3. https://doi.org/10.3389/fonc.2013.00052.
Bagley, Stephen J., Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee,
Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, et al. 2022.
“Glioblastoma Clinical Trials: Current Landscape and Opportunities
for Improvement.” Clinical Cancer Research 28 (4):
594–602. https://doi.org/10.1158/1078-0432.CCR-21-2750.
Bailey, Jennifer M., Pankaj K. Singh, and Michael A. Hollingsworth.
2007. “Cancer Metastasis Facilitated by Developmental Pathways:
Sonic Hedgehog, Notch, and Bone Morphogenic Proteins.”
Journal of Cellular Biochemistry 102 (4): 829–39. https://doi.org/10.1002/jcb.21509.
Balk, Sophie J. 2011. “Ultraviolet Radiation: A Hazard to Children
and Adolescents.” Pediatrics 127 (3): e791–817. https://doi.org/10.1542/peds.2010-3502.
Bao, Shideng, Qiulian Wu, Roger E. McLendon, Yueling Hao, Qing Shi,
Anita B. Hjelmeland, Mark W. Dewhirst, Darell D. Bigner, and Jeremy N.
Rich. 2006. “Glioma Stem Cells Promote Radioresistance by
Preferential Activation of the DNA Damage Response.”
Nature 444 (7120): 756–60. https://doi.org/10.1038/nature05236.
Bartoszyński, Robert, Lutz Edler, Leonid Hanin, Annette Kopp-Schneider,
Lyudmila Pavlova, Alexander Tsodikov, Alexander Zorin, and Andrej Yu.
Yakovlev. 2001. “Modeling Cancer Detection: Tumor Size as a Source
of Information on Unobservable Stages of Carcinogenesis.”
Mathematical Biosciences 171 (2): 113–42. https://doi.org/10.1016/s0025-5564(01)00058-x.
Baskar, Rajamanickam, Kuo Ann Lee, Richard Yeo, and Kheng-Wei Yeoh.
2012. “Cancer and Radiation Therapy: Current Advances and Future
Directions.” International Journal of Medical Sciences 9
(3): 193–99. https://doi.org/10.7150/ijms.3635.
Bonnet, Dominique, and John E. Dick. 1997. “Human Acute Myeloid
Leukemia Is Organized as a Hierarchy That Originates from a Primitive
Hematopoietic Cell.” Nature Medicine 3 (7): 730–37. https://doi.org/10.1038/nm0797-730.
Breward, C. 2003. “A Multiphase Model Describing Vascular Tumour
Growth.” Bulletin of Mathematical Biology 65 (4):
609–40. https://doi.org/10.1016/S0092-8240(03)00027-2.
Cardinal, Olivia, Chloé Burlot, Yangxin Fu, Powel Crosley, Mary Hitt,
Morgan Craig, and Adrianne L. Jenner. 2022. “Establishing
Combination PAC-1 and TRAIL Regimens for Treating Ovarian
Cancer Based on Patient-Specific Pharmacokinetic Profiles
Using in Silico Clinical Trials.”
Computational and Systems Oncology 2 (2). https://doi.org/10.1002/cso2.1035.
Carén, Helena, Stephan Beck, and Steven M. Pollard. 2016.
“Differentiation Therapy for Glioblastoma Too Many
Obstacles?” Molecular & Cellular Oncology 3 (2):
e1124174. https://doi.org/10.1080/23723556.2015.1124174.
Chaichana, Kaisorn L., Eibar Ernesto Cabrera-Aldana, Ignacio
Jusue-Torres, Olindi Wijesekera, Alessandro Olivi, Maryam Rahman, and
Alfredo Quinones-Hinojosa. 2014. “When Gross Total Resection of a
Glioblastoma Is Possible, How Much Resection Should Be Achieved?”
World Neurosurgery 82 (1-2): e257–65. https://doi.org/10.1016/j.wneu.2014.01.019.
Cloughesy, Timothy F., Kevin Petrecca, Tobias Walbert, Nicholas
Butowski, Michael Salacz, James Perry, Denise Damek, et al. 2020.
“Effect of Vocimagene Amiretrorepvec in Combination With
Flucytosine Vs Standard of Care on Survival Following Tumor Resection in
Patients With Recurrent High-Grade Glioma: A Randomized Clinical
Trial.” JAMA Oncology 6 (12): 1939. https://doi.org/10.1001/jamaoncol.2020.3161.
Craig, Morgan, Jana L. Gevertz, Irina Kareva, and Kathleen P. Wilkie.
2023. “A Practical Guide for the Generation of Model-Based Virtual
Clinical Trials.” Frontiers in Systems Biology 3 (June).
https://doi.org/10.3389/fsysb.2023.1174647.
De Thé, Hugues. 2018. “Differentiation Therapy Revisited.”
Nature Reviews Cancer 18 (2): 117–27. https://doi.org/10.1038/nrc.2017.103.
Dingli, David, and Franziska Michor. 2006. “Successful Therapy
Must Eradicate Cancer Stem Cells.” STEM CELLS 24 (12):
2603–10. https://doi.org/10.1634/stemcells.2006-0136.
Dirks, Peter B. 2006. “Stem Cells and Brain Tumours.”
Nature 444 (7120): 687–88. https://doi.org/10.1038/444687a.
Doucette, Tiffany, Ganesh Rao, Yuhui Yang, Joy Gumin, Naoki Shinojima,
B. Nebiyou Bekele, Wei Qiao, Wei Zhang, and Frederick F. Lang. 2011.
“Mesenchymal Stem Cells Display Tumor-Specific Tropism in an
RCAS/Ntv-a Glioma Model.” Neoplasia 13 (8): 716–25. https://doi.org/10.1593/neo.101680.
Dowden, Helen, and Jamie Munro. 2019. “Trends in Clinical Success
Rates and Therapeutic Focus.” Nature Reviews Drug
Discovery 18 (7): 495–96. https://doi.org/10.1038/d41573-019-00074-z.
Enderling, Heiko, Alexander R. A. Anderson, Mark A. J. Chaplain, Afshin
Beheshti, Lynn Hlatky, and Philip Hahnfeldt. 2009. “Paradoxical
Dependencies of Tumor Dormancy and Progression on Basic Cell
Kinetics.” Cancer Research 69 (22): 8814–21. https://doi.org/10.1158/0008-5472.CAN-09-2115.
Farias, Virgina, Vinitha Rani, Natanael Zacro, Mieu Brooks, Naveen
Nagaiah, Henry Ruiz-Garcia, Rachel Sarabia-Estrada, et al. n.d.a.
“BMP4-Secreting MSCs Derived from Human Adipose Tissue
Radiosensitize Glioblastoma Stem Cells via Downregulation of OLIG2
Signaling Pathway.” In Preparation.
———, et al. n.d.b. “BMP4-Secreting MSCs Derived from Human Adipose
Tissue Radiosensitize Glioblastoma Stem Cells via Downregulation of
OLIG2 Signaling Pathway.” In Preparation.
Folkman, Judah, and Raghu Kalluri. 2004. “Cancer Without
Disease.” Nature 427 (6977): 787–87. https://doi.org/10.1038/427787a.
Galli, Rossella, Elena Binda, Ugo Orfanelli, Barbara Cipelletti, Angela
Gritti, Simona De Vitis, Roberta Fiocco, Chiara Foroni, Francesco
Dimeco, and Angelo Vescovi. 2004. “Isolation and Characterization
of Tumorigenic, Stem-Like Neural Precursors from Human
Glioblastoma.” Cancer Research 64 (19): 7011–21. https://doi.org/10.1158/0008-5472.CAN-04-1364.
Gao, Xuefeng, J. Tyson McDonald, Lynn Hlatky, and Heiko Enderling. 2013.
“Acute and Fractionated Irradiation Differentially Modulate Glioma
Stem Cell Division Kinetics.” Cancer Research 73 (5):
1481–90. https://doi.org/10.1158/0008-5472.CAN-12-3429.
Griffin, Robert J. 2006. “Radiobiology for the Radiologist, 6th
Edition.” International Journal of Radiation
Oncology*Biology*Physics 66 (2): 627. https://doi.org/10.1016/j.ijrobp.2006.06.027.
Guerrero-Cázares, Hugo, Stephany Y. Tzeng, Noah P. Young, Ameer O.
Abutaleb, Alfredo Quiñones-Hinojosa, and Jordan J. Green. 2014.
“Biodegradable Polymeric Nanoparticles Show High Efficacy and
Specificity at DNA Delivery to Human Glioblastoma in
Vitro and in Vivo.” ACS
Nano 8 (5): 5141–53. https://doi.org/10.1021/nn501197v.
Hanahan, Douglas, and Robert A Weinberg. 2000. “The Hallmarks of
Cancer.” Cell 100 (1): 57–70. https://doi.org/10.1016/S0092-8674(00)81683-9.
Hemmati, Houman D., Ichiro Nakano, Jorge A. Lazareff, Michael
Masterman-Smith, Daniel H. Geschwind, Marianne Bronner-Fraser, and
Harley I. Kornblum. 2003. “Cancerous Stem Cells Can Arise from
Pediatric Brain Tumors.” Proceedings of the National Academy
of Sciences 100 (25): 15178–83. https://doi.org/10.1073/pnas.2036535100.
Hillen, Thomas, Heiko Enderling, and Philip Hahnfeldt. 2013. “The
Tumor Growth Paradox and Immune System-Mediated Selection for Cancer
Stem Cells.” Bulletin of Mathematical Biology 75 (1):
161–84. https://doi.org/10.1007/s11538-012-9798-x.
Hitomi, Masahiro, Anastasia P. Chumakova, Daniel J. Silver, Arnon M.
Knudsen, W. Dean Pontius, Stephanie Murphy, Neha Anand, Bjarne W.
Kristensen, and Justin D. Lathia. 2021a. “Asymmetric Cell Division
Promotes Therapeutic Resistance in Glioblastoma Stem Cells.”
JCI Insight 6 (3): e130510. https://doi.org/10.1172/jci.insight.130510.
———. 2021b. “Asymmetric Cell Division Promotes Therapeutic
Resistance in Glioblastoma Stem Cells.” JCI Insight 6
(3): e130510. https://doi.org/10.1172/jci.insight.130510.
Hubbard, M. E., and H. M. Byrne. 2013. “Multiphase Modelling of
Vascular Tumour Growth in Two Spatial Dimensions.” Journal of
Theoretical Biology 316 (January): 70–89. https://doi.org/10.1016/j.jtbi.2012.09.031.
Ignatova, Tatyana N., Valery G. Kukekov, Eric D. Laywell, Oleg N.
Suslov, Frank D. Vrionis, and Dennis A. Steindler. 2002. “Human
Cortical Glial Tumors Contain Neural Stem-Like Cells
Expressing Astroglial and Neuronal Markers in Vitro.”
Glia 39 (3): 193–206. https://doi.org/10.1002/glia.10094.
Kim, Eunjung, Vito W. Rebecca, Keiran S. M. Smalley, and Alexander R. A.
Anderson. 2016. “Phase i Trials in Melanoma: A Framework to
Translate Preclinical Findings to the Clinic.” European
Journal of Cancer 67 (November): 213–22. https://doi.org/10.1016/j.ejca.2016.07.024.
Kim, Jayoung, Sujan K. Mondal, Stephany Y. Tzeng, Yuan Rui, Rawan
Al-kharboosh, Kristen K. Kozielski, Adip G. Bhargav, Cesar A. Garcia,
Alfredo Quiñones-Hinojosa, and Jordan J. Green. 2020.
“Poly(ethylene Glycol)Poly(beta-Amino Ester)-Based
Nanoparticles for Suicide Gene Therapy Enhance Brain Penetration and
Extend Survival in a Preclinical Human Glioblastoma Orthotopic Xenograft
Model.” ACS Biomaterials Science & Engineering 6
(5): 2943–55. https://doi.org/10.1021/acsbiomaterials.0c00116.
Lander, Arthur D, Kimberly K Gokoffski, Frederic Y. M Wan, Qing Nie, and
Anne L Calof. 2009. “Cell Lineages and the Logic of Proliferative
Control.” Edited by Charles F Stevens. PLoS Biology 7
(1): e1000015. https://doi.org/10.1371/journal.pbio.1000015.
Lapidot, Tsvee, Christian Sirard, Josef Vormoor, Barbara Murdoch, Trang
Hoang, Julio Caceres-Cortes, Mark Minden, Bruce Paterson, Michael A.
Caligiuri, and John E. Dick. 1994. “A Cell Initiating Human Acute
Myeloid Leukaemia After Transplantation into SCID Mice.”
Nature 367 (6464): 645–48. https://doi.org/10.1038/367645a0.
Lathia, J D, M Hitomi, J Gallagher, S P Gadani, J Adkins, A Vasanji, L
Liu, et al. 2011. “Distribution of CD133 Reveals Glioma Stem Cells
Self-Renew Through Symmetric and Asymmetric Cell Divisions.”
Cell Death & Disease 2 (9): e200–200. https://doi.org/10.1038/cddis.2011.80.
Lee, Yeri, Jin-Ku Lee, Sun Hee Ahn, Jeongwu Lee, and Do-Hyun Nam. 2016.
“WNT Signaling in Glioblastoma and Therapeutic
Opportunities.” Laboratory Investigation 96 (2): 137–50.
https://doi.org/10.1038/labinvest.2015.140.
Li, Qian, Olindi Wijesekera, Sussan J. Salas, Joanna Y. Wang, Mingxin
Zhu, Colette Aprhys, Kaisorn L. Chaichana, et al. 2014a.
“Mesenchymal Stem Cells from Human Fat Engineered to Secrete BMP4
Are Nononcogenic, Suppress Brain Cancer, and Prolong Survival.”
Clinical Cancer Research 20 (9): 2375–87. https://doi.org/10.1158/1078-0432.CCR-13-1415.
———, et al. 2014b. “Mesenchymal Stem Cells from Human Fat
Engineered to Secrete BMP4 Are Nononcogenic, Suppress Brain Cancer, and
Prolong Survival.” Clinical Cancer Research 20 (9):
2375–87. https://doi.org/10.1158/1078-0432.CCR-13-1415.
Lowengrub, J S, H B Frieboes, F Jin, Y-L Chuang, X Li, P Macklin, S M
Wise, and V Cristini. 2010. “Nonlinear Modelling of Cancer:
Bridging the Gap Between Cells and Tumours.”
Nonlinearity 23 (1): R1–91. https://doi.org/10.1088/0951-7715/23/1/R01.
Ma, Qianquan, Wenyong Long, Changsheng Xing, Junjun Chu, Mei Luo, Helen
Y. Wang, Qing Liu, and Rong-Fu Wang. 2018. “Cancer Stem Cells and
Immunosuppressive Microenvironment in Glioma.” Frontiers in
Immunology 9 (December): 2924. https://doi.org/10.3389/fimmu.2018.02924.
Majumdar, Sreemita, and Song-Tao Liu. 2020. “Cell Division
Symmetry Control and Cancer Stem Cells.” AIMS Molecular
Science 7 (2): 82–101. https://doi.org/10.3934/molsci.2020006.
Mangraviti, Antonella, Stephany Y. Tzeng, David Gullotti, Kristen L.
Kozielski, Jennifer E. Kim, Michael Seng, Sara Abbadi, et al. 2016a.
“Non-Virally Engineered Human Adipose Mesenchymal Stem Cells
Produce BMP4, Target Brain Tumors, and Extend Survival.”
Biomaterials 100 (September): 53–66. https://doi.org/10.1016/j.biomaterials.2016.05.025.
———, et al. 2016b. “Non-Virally Engineered Human Adipose
Mesenchymal Stem Cells Produce BMP4, Target Brain Tumors, and Extend
Survival.” Biomaterials 100 (September): 53–66. https://doi.org/10.1016/j.biomaterials.2016.05.025.
McMahon, Stephen Joseph. 2018. “The Linear Quadratic Model: Usage,
Interpretation and Challenges.” Physics in Medicine &
Biology 64 (1): 01TR01. https://doi.org/10.1088/1361-6560/aaf26a.
Meza, Rafael, Jihyoun Jeon, Suresh H. Moolgavkar, and E. Georg Luebeck.
2008. “Age-Specific Incidence of Cancer: Phases, Transitions, and
Biological Implications.” Proceedings of the National Academy
of Sciences 105 (42): 16284–89. https://doi.org/10.1073/pnas.0801151105.
Narita, Yoshitaka, Yoshiki Arakawa, Fumiyuki Yamasaki, Ryo Nishikawa,
Tomokazu Aoki, Masayuki Kanamori, Motoo Nagane, et al. 2019. “A
Randomized, Double-Blind, Phase III Trial of Personalized Peptide
Vaccination for Recurrent Glioblastoma.” Neuro-Oncology
21 (3): 348–59. https://doi.org/10.1093/neuonc/noy200.
Nayak, Sonali, Ashorne Mahenthiran, Yongyong Yang, Mark McClendon,
Barbara Mania-Farnell, Charles David James, John A. Kessler, et al.
2020. “Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like
Cells for Malignant Glioma Treatment: Latest Advances and Implications
for Clinical Application.” Cancers 12 (2): 516. https://doi.org/10.3390/cancers12020516.
Neves-E-Castro, Manuel. 2006. “Why Do Some Breast Cancer Cells
Remain Dormant?” Gynecological Endocrinology 22 (4):
190–97. https://doi.org/10.1080/09513590600624374.
O’Rourke, S. F. C., H. McAneney, and T. Hillen. 2009. “Linear
Quadratic and Tumour Control Probability Modelling in External Beam
Radiotherapy.” Journal of Mathematical Biology 58 (4-5):
799–817. https://doi.org/10.1007/s00285-008-0222-y.
Ostrom, Quinn T, Gino Cioffi, Haley Gittleman, Nirav Patil, Kristin
Waite, Carol Kruchko, and Jill S Barnholtz-Sloan. 2019. “CBTRUS
Statistical Report: Primary Brain and Other Central Nervous System
Tumors Diagnosed in the United States in 20122016.”
Neuro-Oncology 21 (Supplement_5): v1–100. https://doi.org/10.1093/neuonc/noz150.
Pannuti, Antonio, Kimberly Foreman, Paola Rizzo, Clodia Osipo, Todd
Golde, Barbara Osborne, and Lucio Miele. 2010. “Targeting Notch to
Target Cancer Stem Cells.” Clinical Cancer Research 16
(12): 3141–52. https://doi.org/10.1158/1078-0432.CCR-09-2823.
Pendleton, Courtney, Qian Li, David A. Chesler, Kristy Yuan, Hugo
Guerrero-Cazares, and Alfredo Quinones-Hinojosa. 2013a.
“Mesenchymal Stem Cells Derived from Adipose Tissue Vs Bone
Marrow: In Vitro Comparison of Their Tropism Towards Gliomas.”
Edited by Joseph Najbauer. PLoS ONE 8 (3): e58198. https://doi.org/10.1371/journal.pone.0058198.
———. 2013b. “Mesenchymal Stem Cells Derived from Adipose Tissue Vs
Bone Marrow: In Vitro Comparison of Their Tropism Towards
Gliomas.” Edited by Joseph Najbauer. PLoS ONE 8 (3):
e58198. https://doi.org/10.1371/journal.pone.0058198.
Piccirillo, S. G. M., B. A. Reynolds, N. Zanetti, G. Lamorte, E. Binda,
G. Broggi, H. Brem, A. Olivi, F. Dimeco, and A. L. Vescovi. 2006.
“Bone Morphogenetic Proteins Inhibit the Tumorigenic Potential of
Human Brain Tumour-Initiating Cells.” Nature 444 (7120):
761–65. https://doi.org/10.1038/nature05349.
Plevritis, Sylvia K., Peter Salzman, Bronislava M. Sigal, and Peter W.
Glynn. 2006. “A Natural History Model of Stage Progression Applied
to Breast Cancer.” Statistics in Medicine 26 (3):
581–95. https://doi.org/10.1002/sim.2550.
Potten, C. S. 1981. “The Cell Kinetic Mechanism for
Radiation-Induced Cellular Depletion of Epithelial Tissue Based on
Hierarchical Differences in Radiosensitivity.” International
Journal of Radiation Biology and Related Studies in Physics, Chemistry
and Medicine 40 (2): 217–25. https://doi.org/10.1080/09553008114551101.
Reardon, David A., Alba A. Brandes, Antonio Omuro, Paul Mulholland,
Michael Lim, Antje Wick, Joachim Baehring, et al. 2020. “Effect of
Nivolumab Vs Bevacizumab in Patients With Recurrent Glioblastoma: The
CheckMate 143 Phase 3 Randomized Clinical Trial.” JAMA
Oncology 6 (7): 1003. https://doi.org/10.1001/jamaoncol.2020.1024.
Reya, Tannishtha, Sean J. Morrison, Michael F. Clarke, and Irving L.
Weissman. 2001. “Stem Cells, Cancer, and Cancer Stem
Cells.” Nature 414 (6859): 105–11. https://doi.org/10.1038/35102167.
Ricci-Vitiani, Lucia, Dario G. Lombardi, Emanuela Pilozzi, Mauro
Biffoni, Matilde Todaro, Cesare Peschle, and Ruggero De Maria. 2007.
“Identification and Expansion of Human Colon-Cancer-Initiating
Cells.” Nature 445 (7123): 111–15. https://doi.org/10.1038/nature05384.
Rich, Jeremy N. 2007. “Cancer Stem Cells in Radiation
Resistance.” Cancer Research 67 (19): 8980–84. https://doi.org/10.1158/0008-5472.CAN-07-0895.
Rockne, R., E. C. Alvord, J. K. Rockhill, and K. R. Swanson. 2009.
“A Mathematical Model for Brain Tumor Response to Radiation
Therapy.” Journal of Mathematical Biology 58 (4-5): 561.
https://doi.org/10.1007/s00285-008-0219-6.
Rockne, R, J K Rockhill, M Mrugala, A M Spence, I Kalet, K Hendrickson,
A Lai, T Cloughesy, E C Alvord, and K R Swanson. 2010. “Predicting
the Efficacy of Radiotherapy in Individual Glioblastoma Patients
in Vivo: A Mathematical Modeling Approach.”
Physics in Medicine and Biology 55 (12): 3271–85. https://doi.org/10.1088/0031-9155/55/12/001.
Roth, Patrick, Thierry Gorlia, Jaap C. Reijneveld, Filip Yves Francine
Leon De Vos, Ahmed Idbaih, Jean-Sebastien Frenel, Emilie Le Rhun, et al.
2021. “EORTC 1709/CCTG CE.8: A Phase III Trial of Marizomib in
Combination with Temozolomide-Based Radiochemotherapy Versus
Temozolomide-Based Radiochemotherapy Alone in Patients with Newly
Diagnosed Glioblastoma.” Journal of Clinical Oncology 39
(15_suppl): 2004–4. https://doi.org/10.1200/JCO.2021.39.15_suppl.2004.
Schonberg, David L., Daniel Lubelski, Tyler E. Miller, and Jeremy N.
Rich. 2014. “Brain Tumor Stem Cells: Molecular Characteristics and
Their Impact on Therapy.” Molecular Aspects of Medicine
39 (October): 82–101. https://doi.org/10.1016/j.mam.2013.06.004.
Sell, S. 1993. “Cellular Origin of Cancer: Dedifferentiation or
Stem Cell Maturation Arrest?” Environmental Health
Perspectives 101 (suppl 5): 15–26. https://doi.org/10.1289/ehp.93101s515.
Singh, Sheila K., Ian D. Clarke, Mizuhiko Terasaki, Victoria E. Bonn,
Cynthia Hawkins, Jeremy Squire, and Peter B. Dirks. 2003.
“Identification of a Cancer Stem Cell in Human Brain
Tumors.” Cancer Research 63 (18): 5821–28.
Singh, Sheila K., Cynthia Hawkins, Ian D. Clarke, Jeremy A. Squire, Jane
Bayani, Takuichiro Hide, R. Mark Henkelman, Michael D. Cusimano, and
Peter B. Dirks. 2004. “Identification of Human Brain Tumour
Initiating Cells.” Nature 432 (7015): 396–401. https://doi.org/10.1038/nature03128.
Smith, Chris L., Kaisorn L. Chaichana, Young M. Lee, Benjamin Lin, Kevin
M. Stanko, Thomas O’Donnell, Saksham Gupta, et al. 2015.
“Pre-Exposure of Human Adipose Mesenchymal Stem Cells to Soluble
Factors Enhances Their Homing to Brain Cancer.” Stem Cells
Translational Medicine 4 (3): 239–51. https://doi.org/10.5966/sctm.2014-0149.
Stiles, Charles D., and David H. Rowitch. 2008. “Glioma Stem
Cells: A Midterm Exam.” Neuron 58 (6): 832–46. https://doi.org/10.1016/j.neuron.2008.05.031.
Stupp, Roger, Warren P. Mason, Martin J. Van Den Bent, Michael Weller,
Barbara Fisher, Martin J. B. Taphoorn, Karl Belanger, et al. 2005.
“Radiotherapy Plus Concomitant and Adjuvant Temozolomide for
Glioblastoma.” New England Journal of Medicine 352 (10):
987–96. https://doi.org/10.1056/NEJMoa043330.
Sweeney, Eamon. 1995. “Dormant Cells in Columnar Cell Carcinoma of
the Thyroid.” Human Pathology 26 (6): 691–92. https://doi.org/10.1016/0046-8177(95)90180-9.
Taipale, Jussi, and Philip A. Beachy. 2001. “The Hedgehog and Wnt
Signalling Pathways in Cancer.” Nature 411 (6835):
349–54. https://doi.org/10.1038/35077219.
Tang, Xuejia, Chenghai Zuo, Pengchao Fang, Guojing Liu, Yongyi Qiu, Yi
Huang, and Rongrui Tang. 2021a. “Targeting Glioblastoma Stem
Cells: A Review on Biomarkers, Signal Pathways and Targeted
Therapy.” Frontiers in Oncology 11 (July): 701291. https://doi.org/10.3389/fonc.2021.701291.
———. 2021b. “Targeting Glioblastoma Stem Cells: A Review on
Biomarkers, Signal Pathways and Targeted Therapy.” Frontiers
in Oncology 11 (July): 701291. https://doi.org/10.3389/fonc.2021.701291.
Turner, C., A. R. Stinchcombe, M. Kohandel, S. Singh, and S.
Sivaloganathan. 2009. “Characterization of Brain Cancer Stem
Cells: A Mathematical Approach.” Cell Proliferation 42
(4): 529–40. https://doi.org/10.1111/j.1365-2184.2009.00619.x.
Tzeng, Stephany Y., Hugo Guerrero-Cázares, Elliott E. Martinez, Joel C.
Sunshine, Alfredo Quiñones-Hinojosa, and Jordan J. Green. 2011.
“Non-Viral Gene Delivery Nanoparticles Based on Poly(beta-Amino
Esters) for Treatment of Glioblastoma.” Biomaterials 32
(23): 5402–10. https://doi.org/10.1016/j.biomaterials.2011.04.016.
Vlashi, Erina, Kwanghee Kim, Chann Lagadec, Lorenza Della Donna, John
Tyson McDonald, Mansoureh Eghbali, James W. Sayre, Encrico Stefani,
William McBride, and Frank Pajonk. 2009. “In Vivo Imaging,
Tracking, and Targeting of Cancer Stem Cells.” JNCI: Journal
of the National Cancer Institute 101 (5): 350–59. https://doi.org/10.1093/jnci/djn509.
Wang, Hanwen, Oleg Milberg, Imke H. Bartelink, Paolo Vicini, Bing Wang,
Rajesh Narwal, Lorin Roskos, Cesar A. Santa-Maria, and Aleksander S.
Popel. 2019. “In Silico Simulation of a
Clinical Trial with Anti-CTLA-4 and Anti-PD-L1 Immunotherapies in
Metastatic Breast Cancer Using a Systems Pharmacology Model.”
Royal Society Open Science 6 (5): 190366. https://doi.org/10.1098/rsos.190366.
Wang, Hanwen, Richard J. Sové, Mohammad Jafarnejad, Sondra Rahmeh,
Elizabeth M. Jaffee, Vered Stearns, Evanthia T. Roussos Torres, Roisin
M. Connolly, and Aleksander S. Popel. 2020. “Conducting a Virtual
Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative
Systems Pharmacology Model with an Epigenetic Modulator and Immune
Checkpoint Inhibitors.” Frontiers in Bioengineering and
Biotechnology 8 (February). https://doi.org/10.3389/fbioe.2020.00141.
Weiss, Lora D., Natalia L. Komarova, and Ignacio A. Rodriguez-Brenes.
2017. “Mathematical Modeling of Normal and Cancer Stem
Cells.” Current Stem Cell Reports 3 (3): 232–39. https://doi.org/10.1007/s40778-017-0094-4.
Weller, Michael, Nicholas Butowski, David D Tran, Lawrence D Recht,
Michael Lim, Hal Hirte, Lynn Ashby, et al. 2017. “Rindopepimut
with Temozolomide for Patients with Newly Diagnosed, EGFRvIII-Expressing
Glioblastoma (ACT IV): A Randomised, Double-Blind, International Phase 3
Trial.” The Lancet Oncology 18 (10): 1373–85. https://doi.org/10.1016/S1470-2045(17)30517-X.
Wu, Chengyue, Guillermo Lorenzo, David A. Hormuth, Ernesto A. B. F.
Lima, Kalina P. Slavkova, Julie C. DiCarlo, John Virostko, et al. 2022.
“Integrating Mechanism-Based Modeling with Biomedical Imaging to
Build Practical Digital Twins for Clinical Oncology.”
Biophysics Reviews 3 (2). https://doi.org/10.1063/5.0086789.
Yan, Min, and Quentin Liu. 2016. “Differentiation Therapy: A
Promising Strategy for Cancer Treatment.” Chinese Journal of
Cancer 35 (1): 3. https://doi.org/10.1186/s40880-015-0059-x.
Yang, Wei, Nicole M. Warrington, Sara J. Taylor, Paula Whitmire, Eduardo
Carrasco, Kyle W. Singleton, Ningying Wu, et al. 2019. “Sex
Differences in GBM Revealed by Analysis of Patient Imaging,
Transcriptome, and Survival Data.” Science Translational
Medicine 11 (473): eaao5253. https://doi.org/10.1126/scitranslmed.aao5253.
Yankeelov, Thomas E., David A. Hormuth, Ernesto A. B. F. Lima, Guillermo
Lorenzo, Chengyue Wu, Lois C. Okereke, Gaiane M. Rauch, Aradhana M.
Venkatesan, and Caroline Chung. 2024. “Designing Clinical Trials
for Patients Who Are Not Average.” iScience 27 (1):
108589. https://doi.org/10.1016/j.isci.2023.108589.
Youssefpour, H., X. Li, A. D. Lander, and J. S. Lowengrub. 2012.
“Multispecies Model of Cell Lineages and Feedback Control in Solid
Tumors.” Journal of Theoretical Biology 304 (July):
39–59. https://doi.org/10.1016/j.jtbi.2012.02.030.
Yu, Victoria Y., Dan Nguyen, Frank Pajonk, Patrick Kupelian, Tania
Kaprealian, Michael Selch, Daniel A. Low, and Ke Sheng. 2015.
“Incorporating Cancer Stem Cells in Radiation Therapy Treatment
Response Modeling and the Implication in Glioblastoma Multiforme
Treatment Resistance.” International Journal of Radiation
Oncology*Biology*Physics 91 (4): 866–75. https://doi.org/10.1016/j.ijrobp.2014.12.004.
Zahid, Mohammad U., Abdallah S. R. Mohamed, Jimmy J. Caudell, Louis B.
Harrison, Clifton D. Fuller, Eduardo G. Moros, and Heiko Enderling.
2021. “Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck
Cancer Radiotherapy Dose Personalization.” Journal of
Personalized Medicine 11 (11): 1124. https://doi.org/10.3390/jpm11111124.